Zentalis Pharmaceuticals, Inc.
ZNTL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $215,372 | $990,946 | $1,064,540 | $3,588,353 |
| - Cash | $33,901 | $28,038 | $43,069 | $59,714 |
| + Debt | $39,577 | $43,150 | $47,328 | $45,912 |
| Enterprise Value | $221,048 | $1,006,058 | $1,068,799 | $3,574,551 |
| Revenue | $67,425 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $67,425 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| EBITDA | -$186,169 | -$247,599 | -$225,861 | -$207,198 |
| % Margin | -276.1% | – | – | – |
| Net Income | -$165,839 | -$292,191 | -$236,806 | -$158,725 |
| % Margin | -246% | – | – | – |
| EPS Diluted | -2.33 | -4.47 | -4.48 | -3.72 |
| % Growth | 47.9% | 0.2% | -20.4% | – |
| Operating Cash Flow | -$170,860 | -$207,822 | -$163,751 | -$154,093 |
| Capital Expenditures | -$221 | -$583 | -$2,548 | -$6,107 |
| Free Cash Flow | -$171,081 | -$208,405 | -$166,299 | -$160,200 |